TrialDiabetes care2014

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

The primary results report of NCT01392573. Its numbers are set against the trial’s posted results below.

What the trial testedas reported · 413 people · 2014

Not counted

−1.10percentage points−1.30 to −0.80

As reported

difference −1.1 %, 95% CI −1.30 to −0.80

Same as the trial’s posted resultThis paper difference −1.10 (−1.30 to −0.80)Posted, primary outcome difference −1.05 (−1.25 to −0.84), p <0.0001Change From Baseline in HbA1c (Glycosylated Haemoglobin)

the abstract, start to end

… IDeg (estimated treatment difference -1.1% [95% CI -1.3, -0.8], -12 …

← favours treatmentfavours comparator →

could be chance

Glycemic control

−1.1−1.30 to −0.80

InsulinGlycemic control

1 / 3

2014

…

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled ittrialcites it